dd-cfDNA Significantly Improves Rejection Yield in Kidney Transplant Biopsies

By afschroeder • August 10, 2025

Bromberg JS, Brennan DC, Taber DJ, Cooper M, Anand S, Akalin E, Huang E, Klein JA, Glehn-Ponsirenas R, Rogers J, Chuang P, Kothari AS, Shen L, Woodward RN, Kumar D, Wojciechowski D, Mandelbrot D, Costa N, Bu L, Weir MR; KOAR investigators. dd-cfDNA Significantly Improves Rejection Yield in Kidney Transplant Biopsies. Am J Transplant. 2025 Aug 6:S1600-6135(25)02875-8. doi: 10.1016/j.ajt.2025.07.2484. Epub ahead of print. PMID: 40780562.

Tags: Biopsy yield, clinical utility of dd-cfDNA, dd-cfDNA, donor derived cell free DNA, KOAR (Kidney allograft Outcomes Allosure Registry). NCT03326076, Nephrology, post-kidney transplant biopsy, Publications, Rejection yield, sub-clinical rejection, surveillance biopsy

Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry

Nguyen MD, Fekrat R, Gee C, Demirci AN, Kharabaf S, Le D, Tadros M, Nguyen VQ, Patel S, Truong T, Ahdoot R, Kurtz IB, Kerr[...]

Management recommendations for kidney transplantation in patients with plasma cell dyscrasia

Murakami N, Blosser CD, Webber AB, Gupta G, Singh N, Boppana S, Master S, Parasuraman R, Campagnaro EL, Java A, Sprangers B, Bhasin-Chhabra B, Lum[...]

Experiences and perspectives of patients and their caregivers on gastrointestinal symptoms in peritoneal dialysis: Workshop report

Hayat A, Johnson DW, Manera K, Viecelli AK, Wilkie M, Shen J, Wang AY, Htay H, Jaure A, Cho Y, Walker R. Experiences and perspectives[...]